Coldstream Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.64M | Buy |
21,717
+5,045
| +30% | +$1.8M | 0.09% | 114 |
|
|
2025
Q4 | $5.46M | Sell |
16,672
-760
| -4% | -$241K | 0.07% | 146 |
|
|
2025
Q3 | $4.92M | Sell |
17,432
-2,441
| -12% | -$708K | 0.07% | 150 |
|
|
2025
Q2 | $5.55M | Buy |
19,873
+1,985
| +11% | +$562K | 0.09% | 128 |
|
|
2025
Q1 | $5.57M | Buy |
17,888
+1,416
| +9% | +$418K | 0.12% | 110 |
|
|
2024
Q4 | $4.29M | Sell |
16,472
-12,174
| -42% | -$3.61M | 0.09% | 137 |
|
|
2024
Q3 | $9.22M | Buy |
28,646
+710
| +3% | +$232K | 0.2% | 71 |
|
|
2024
Q2 | $8.73M | Buy |
27,936
+1,216
| +5% | +$357K | 0.21% | 66 |
|
|
2024
Q1 | $7.6M | Buy |
26,720
+215
| +0.8% | +$62.9K | 0.19% | 76 |
|
|
2023
Q4 | $7.63M | Buy |
26,505
+11,839
| +81% | +$3.23M | 0.21% | 64 |
|
|
2023
Q3 | $3.94M | Buy |
14,666
+4,424
| +43% | +$1.1M | 0.13% | 111 |
|
|
2023
Q2 | $2.27M | Sell |
10,242
-241
| -2% | -$55.9K | 0.07% | 154 |
|
|
2023
Q1 | $2.53M | Sell |
10,483
-250
| -2% | -$61.4K | 0.09% | 145 |
|
|
2022
Q4 | $2.82M | Buy |
+10,733
| New | +$2.88M | 0.1% | 131 |
|
|
2022
Q2 | $3.78M | Buy |
15,531
+1,439
| +10% | +$353K | 0.15% | 107 |
|
|
2022
Q1 | $3.41M | Buy |
14,092
+1,465
| +12% | +$337K | 0.12% | 111 |
|
|
2021
Q4 | $2.84M | Sell |
12,627
-6,577
| -34% | -$1.39M | 0.09% | 143 |
|
|
2021
Q3 | $4.88M | Buy |
19,204
+13,870
| +260% | +$3.19M | 0.24% | 59 |
|
|
2021
Q2 | $1.3M | Buy |
5,334
+483
| +10% | +$119K | 0.05% | 195 |
|
|
2021
Q1 | $1.21M | Sell |
4,851
-13,195
| -73% | -$3.15M | 0.07% | 160 |
|
|
2020
Q4 | $4.15M | Buy |
18,046
+1,097
| +6% | +$253K | 0.25% | 60 |
|
|
2020
Q3 | $4.31M | Buy |
16,949
+102
| +0.6% | +$25.3K | 0.36% | 40 |
|
|
2020
Q2 | $3.97M | Sell |
16,847
-1,442
| -8% | -$329K | 0.36% | 42 |
|
|
2020
Q1 | $3.71M | Sell |
18,289
-981
| -5% | -$214K | 0.41% | 36 |
|
|
2019
Q4 | $4.64M | Buy |
19,270
+195
| +1% | +$43K | 0.38% | 41 |
|
|
2019
Q3 | $3.69M | Buy |
19,075
+698
| +4% | +$134K | 0.31% | 58 |
|
|
2019
Q2 | $3.39M | Sell |
18,377
-153
| -0.8% | -$27.4K | 0.28% | 66 |
|
|
2019
Q1 | $3.52M | Buy |
18,530
+1,227
| +7% | +$234K | 0.31% | 62 |
|
|
2018
Q4 | $3.37M | Buy |
17,303
+427
| +3% | +$83.3K | 0.33% | 62 |
|
|
2018
Q3 | $3.5M | Buy |
16,876
+723
| +4% | +$142K | 0.32% | 57 |
|
|
2018
Q2 | $2.98M | Buy |
16,153
+293
| +2% | +$51.8K | 0.3% | 62 |
|
|
2018
Q1 | $2.7M | Sell |
15,860
-587
| -4% | -$108K | 0.29% | 65 |
|
|
2017
Q4 | $2.86M | Buy |
16,447
+519
| +3% | +$91.8K | 0.31% | 68 |
|
|
2017
Q3 | $2.97M | Buy |
15,928
+970
| +6% | +$172K | 0.35% | 62 |
|
|
2017
Q2 | $2.58M | Buy |
14,958
+1,457
| +11% | +$237K | 0.33% | 59 |
|
|
2017
Q1 | $2.21M | Buy |
13,501
+154
| +1% | +$25.6K | 0.31% | 62 |
|
|
2016
Q4 | $1.95M | Buy |
13,347
+1,004
| +8% | +$151K | 0.32% | 66 |
|
|
2016
Q3 | $2.06M | Sell |
12,343
-789
| -6% | -$133K | 0.36% | 46 |
|
|
2016
Q2 | $2M | Sell |
13,132
-32
| -0.2% | -$4.97K | 0.35% | 51 |
|
|
2016
Q1 | $1.97M | Sell |
13,164
-376
| -3% | -$55.9K | 0.36% | 46 |
|
|
2015
Q4 | $2.2M | Buy |
13,540
+888
| +7% | +$140K | 0.48% | 32 |
|
|
2015
Q3 | $1.75M | Buy |
+12,652
| New | +$1.99M | 0.47% | 56 |
|
Other funds holding AMGN
VCM
VPM
Coldstream Capital Management's AMGN Position: Q1 2026 in Review
Coldstream Capital Management increased its Amgen (AMGN) stake by 30% in Q1 2026, buying an estimated $1.8M and bringing the position to 21,717 shares worth $7.64M. The position accounts for 0.09% of the portfolio, ranked #114.
Coldstream Capital Management first reported a position in AMGN in Q3 2015 and has held it in 42 quarters since. The position peaked at $9.22M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Coldstream Capital Management held 21,717 shares of Amgen worth $7.64M as of Q1 2026.
- Coldstream Capital Management bought 5,045 Amgen shares in Q1 2026, an estimated $1.8M.
- Amgen made up 0.09% of Coldstream Capital Management's portfolio in Q1 2026, its #114 holding.
- Coldstream Capital Management first reported a position in Amgen in Q3 2015 and has held it in 42 quarters since.
- Coldstream Capital Management's Amgen position peaked at $9.22M in Q3 2024.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.